341 related articles for article (PubMed ID: 8516059)
1. Surfactant therapy in full-term neonates with severe respiratory failure.
Khammash H; Perlman M; Wojtulewicz J; Dunn M
Pediatrics; 1993 Jul; 92(1):135-9. PubMed ID: 8516059
[TBL] [Abstract][Full Text] [Related]
2. Surfactant therapy in neonates with respiratory deterioration due to pulmonary hemorrhage.
Pandit PB; Dunn MS; Colucci EA
Pediatrics; 1995 Jan; 95(1):32-6. PubMed ID: 7770305
[TBL] [Abstract][Full Text] [Related]
3. Use of surfactant in pulmonary disorders in full-term infants.
Sun B
Curr Opin Pediatr; 1996 Apr; 8(2):113-7. PubMed ID: 8723804
[TBL] [Abstract][Full Text] [Related]
4. Extracorporeal membrane oxygenation in infants with meconium aspiration syndrome: a decade of experience with venovenous ECMO.
Kugelman A; Gangitano E; Taschuk R; Garza R; Riskin A; McEvoy C; Durand M
J Pediatr Surg; 2005 Jul; 40(7):1082-9. PubMed ID: 16034749
[TBL] [Abstract][Full Text] [Related]
5. Repeat surfactant therapy for postsurfactant slump.
Katz LA; Klein JM
J Perinatol; 2006 Jul; 26(7):414-22. PubMed ID: 16724122
[TBL] [Abstract][Full Text] [Related]
6. The role of surfactant treatment in preterm infants and term newborns with acute respiratory distress syndrome.
Wirbelauer J; Speer CP
J Perinatol; 2009 May; 29 Suppl 2():S18-22. PubMed ID: 19399004
[TBL] [Abstract][Full Text] [Related]
7. Bovine surfactant in full-term neonates with adult respiratory distress syndrome-like disorders.
Gortner L; Pohlandt F; Bartmann P
Pediatrics; 1994 Mar; 93(3):538. PubMed ID: 8115229
[No Abstract] [Full Text] [Related]
8. Bovine surfactant replacement therapy in neonates of less than 30 weeks' gestation: a randomized controlled trial of prophylaxis versus treatment.
Dunn MS; Shennan AT; Zayack D; Possmayer F
Pediatrics; 1991 Mar; 87(3):377-86. PubMed ID: 2000278
[TBL] [Abstract][Full Text] [Related]
9. Surfactant treatment of full-term newborns with respiratory failure.
Auten RL; Notter RH; Kendig JW; Davis JM; Shapiro DL
Pediatrics; 1991 Jan; 87(1):101-7. PubMed ID: 1984603
[TBL] [Abstract][Full Text] [Related]
10. Surfactant-replacement therapy for respiratory distress in the preterm and term neonate.
Engle WA;
Pediatrics; 2008 Feb; 121(2):419-32. PubMed ID: 18245434
[TBL] [Abstract][Full Text] [Related]
11. Predictors of failure of high-frequency oscillatory ventilation in term infants with severe respiratory failure.
Paranka MS; Clark RH; Yoder BA; Null DM
Pediatrics; 1995 Mar; 95(3):400-4. PubMed ID: 7862480
[TBL] [Abstract][Full Text] [Related]
12. [Prevention and treatment of respiratory distress syndrome in premature infants using intratracheally administered surfactants].
de Winter JP; Egberts J; de Kleine MJ; van Bel F; Wijnands JB; Guit GL
Ned Tijdschr Geneeskd; 1992 Oct; 136(41):2018-24. PubMed ID: 1407193
[TBL] [Abstract][Full Text] [Related]
13. Single- versus multiple-dose surfactant replacement therapy in neonates of 30 to 36 weeks' gestation with respiratory distress syndrome.
Dunn MS; Shennan AT; Possmayer F
Pediatrics; 1990 Oct; 86(4):564-71. PubMed ID: 2216622
[TBL] [Abstract][Full Text] [Related]
14. [Use of surfactant in respiratory diseases in neonates and infants].
Marraro G
Cah Anesthesiol; 1994; 42(2):159-66. PubMed ID: 8087630
[TBL] [Abstract][Full Text] [Related]
15. Effects of surfactant treatment on gas-exchange and clinical course in near-term newborns with RDS.
Golombek SG; Truog WE
J Perinat Med; 2000; 28(6):436-42. PubMed ID: 11155428
[TBL] [Abstract][Full Text] [Related]
16. [Surfactant treatment of acute pulmonary failure. Other indications than neonatal distress syndrome].
Silberg IE; Grønn M
Tidsskr Nor Laegeforen; 1997 Apr; 117(10):1456-8. PubMed ID: 9198922
[TBL] [Abstract][Full Text] [Related]
17. One-year follow-up of very preterm infants who received lucinactant for prevention of respiratory distress syndrome: results from 2 multicenter randomized, controlled trials.
Moya F; Sinha S; Gadzinowski J; D'Agostino R; Segal R; Guardia C; Mazela J; Liu G;
Pediatrics; 2007 Jun; 119(6):e1361-70. PubMed ID: 17533176
[TBL] [Abstract][Full Text] [Related]
18. Multicenter trial of single-dose modified bovine surfactant extract (Survanta) for prevention of respiratory distress syndrome. Ross Collaborative Surfactant Prevention Study Group.
Soll RF; Hoekstra RE; Fangman JJ; Corbet AJ; Adams JM; James LS; Schulze K; Oh W; Roberts JD; Dorst JP
Pediatrics; 1990 Jun; 85(6):1092-102. PubMed ID: 2187176
[TBL] [Abstract][Full Text] [Related]
19. Surfactant replacement therapy for severe neonatal respiratory distress syndrome: an international randomized clinical trial. Collaborative European Multicenter Study Group.
Pediatrics; 1988 Nov; 82(5):683-91. PubMed ID: 2903480
[TBL] [Abstract][Full Text] [Related]
20. [Effects of surfactant administration in premature infants with severe respiratory distress syndrome].
Morón A; Luaces J; Esteban JC; Medina D; Sánchez JM; Manzano JL
Med Clin (Barc); 1996 Jun; 107(5):165-8. PubMed ID: 8758674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
